Metabolic effects and the methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with neural tube defects in southern brazil

被引:30
作者
Félix, TM [1 ]
Leistner, S [1 ]
Giugliani, R [1 ]
机构
[1] Hosp Clin Porto Alegre, Med Genet Serv, Porto Alegre, RS, Brazil
关键词
neural tube defects; folate; vitamin B12; homocysteine; methylenetetrahydrofolate reductase; MTHFR; 677C > T; 1298A > C;
D O I
10.1002/bdra.20011
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
BACKGROUND: The importance of metabolic factors in neural tube defects (NTDs) has been the focus of many investigations. Several authors have suggested that abnormalities in homocysteine metabolism, such as hyperhomocysteinemia, folate deficiency, and low vitamin B12, may be responsible for these malformations and that both nutritional factors and genetic abnormalities are associated with them. METHODS: We conducted a case-control study to investigate the influence of biochemical and genetic factors in NTDs in infants in southern Brazil. Levels of folate, vitamin B12, total homocysteine (t-Hcy) and the 677C>T and 1298A>C polymorphisms of the MTHFR gene were analyzed in 41 NTD child-mother pairs and 44 normal child-mother control pairs. RESULTS: Subjects in the case group had a higher mean blood folate level than those in the control group. The level of vitamin B12 was lower in mothers in the NTD group than in control mothers (p = 0.004). The level of t-Hcy was not different in the two groups, but t-Hcy and vitamin B12 were correlated (p = 0.002). There was no difference in the genotype distribution for 677C>T and 1298A>C polymorphisms of MTHFR in the case and control pairs. The level of t-Hcy was correlated with 677TT. CONCLUSIONS: Despite the small sample in this study, we suggest that low vitamin B12 and, consequently, hyperhomocysteinemia are important risk factors for NTDs in our population. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:459 / 463
页数:5
相关论文
共 40 条
[1]  
Arruda VR, 1998, AM J MED GENET, V78, P332, DOI 10.1002/(SICI)1096-8628(19980724)78:4<332::AID-AJMG5>3.0.CO
[2]  
2-N
[3]   Prevention of neural-tube defects with folic acid in China [J].
Berry, RJ ;
Li, Z ;
Erickson, JD ;
Li, S ;
Moore, CA ;
Wang, H ;
Mulinare, J ;
Zhao, P ;
Wong, LYC ;
Gindler, J ;
Hong, SX ;
Correa, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (20) :1485-1490
[4]  
Botto LD, 2000, AM J EPIDEMIOL, V151, P862
[5]  
Brönstrup A, 1998, AM J CLIN NUTR, V68, P1104
[6]   EPIDEMIOLOGY OF NEURAL-TUBE DEFECTS IN SOUTH-AMERICA [J].
CASTILLA, EE ;
ORIOLI, IM .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1985, 22 (04) :695-702
[7]  
Christensen B, 1999, AM J MED GENET, V84, P151, DOI 10.1002/(SICI)1096-8628(19990521)84:2<151::AID-AJMG12>3.0.CO
[8]  
2-T
[9]   Metabolic effects of C677T and A1298C mutations at the MTHFR gene in Brazilian children with neural tube defects [J].
Cunha, ALA ;
Hirata, MH ;
Kim, CA ;
Guerra-Shinohara, EM ;
Nonoyama, K ;
Hirata, RDC .
CLINICA CHIMICA ACTA, 2002, 318 (1-2) :139-143
[10]   PREVENTION OF THE 1ST OCCURRENCE OF NEURAL-TUBE DEFECTS BY PERICONCEPTIONAL VITAMIN SUPPLEMENTATION [J].
CZEIZEL, AE ;
DUDAS, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (26) :1832-1835